DCM
BIIB icon

Decatur Capital Management’s Biogen BIIB Stock Holding History

Decatur Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-29,135
Closed -$7.98M – 53
2018
Q1 		$7.98M Buy
+29,135
New +$9.04M 1.64% 35
2016
Q2 		– Sell
-48,450
Closed -$12.6M – 99
2016
Q1 		$12.6M Buy
48,450
+5,575
+13% +$1.47M 1.65% 39
2015
Q4 		$13.1M Sell
42,875
-225
-0.5% -$64.7K 1.69% 30
2015
Q3 		$12.6M Buy
+43,100
New +$14.2M 1.72% 33

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Decatur Capital Management's BIIB Position: Q2 2018 in Review

Decatur Capital Management sold out of Biogen (BIIB) in Q2 2018, closing a stake of 29,135 shares — an estimated $7.98M sold.

Decatur Capital Management first reported a position in BIIB in Q3 2015 and held it in 4 quarters. The position peaked at $13.1M in Q4 2015. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Decatur Capital Management reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Decatur Capital Management sold 29,135 Biogen shares in Q2 2018, an estimated $7.98M.
  • Decatur Capital Management first reported a position in Biogen in Q3 2015 and held it in 4 quarters.
  • Decatur Capital Management's Biogen position peaked at $13.1M in Q4 2015.
  • 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Decatur Capital Management's 13F filing for Q2 2018, filed 1 Aug 2018.